Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Darton

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMC Psychiatry|July 6, 2016
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medicationJoanna Moncrieff, Kiran Azam, Sonia Johnson, et al.
BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trialJoanna Moncrieff, Nadia Crellin, Jacki Stansfeld, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMC Psychiatry|July 6, 2016
Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medicationJoanna Moncrieff, Kiran Azam, Sonia Johnson, et al.
BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
The Lancet. Psychiatry|October 1, 2023
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trialJoanna Moncrieff, Nadia Crellin, Jacki Stansfeld, et al.
Pageof 1